[blaurenceclark]

Actually the AI portion of our product is mostly for making clinical trial recruitment more efficient, although we consciously add demographic tweaks to our algorithms to help identify specific patient populations that many researchers simply don't think about.

What we are also working on to make things more fair is helping open critical clinical trials in areas where there is a higher density of minority populations, as well as using demographic data in identifying where minority patients exist that match up to the latest clinical trials to prove to pharma companies that opening them in those areas is not only a moral improvement, but a financial one as well. (Disclaimer we do all of this de-identified).

Would definitely be great to have a larger discussion on this topic!